治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3141人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1904967, encodeId=4d25190496ea4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=原发性胆汁性肝硬化预后判断及其治疗方案, objectType=article, longId=73853, objectId=78c3e385305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78c3e385305, replyNumber=0, likeNumber=60, createdTime=2017-04-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78c3e385305, moduleTitle=原发性胆汁性肝硬化预后判断及其治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78c3e385305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904972, encodeId=586819049e2ca, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA Oncol：同样的治疗方案，不同部位的结肠癌，疗效却相反, objectType=article, longId=79910, objectId=9a85e9910c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a85e9910c0, replyNumber=0, likeNumber=57, createdTime=2017-03-10, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a85e9910c0, moduleTitle=JAMA Oncol：同样的治疗方案，不同部位的结肠癌，疗效却相反, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a85e9910c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904968, encodeId=86ff1904968c7, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet子刊：晚期肾脏疾病患者应怎样选择他汀类药物治疗方案？, objectType=article, longId=74028, objectId=e28ee4028b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e28ee4028b9, replyNumber=0, likeNumber=50, createdTime=2016-12-18, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e28ee4028b9, moduleTitle=Lancet子刊：晚期肾脏疾病患者应怎样选择他汀类药物治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e28ee4028b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904961, encodeId=0263190496158, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, objectType=article, longId=59145, objectId=256459145ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=256459145ee, replyNumber=0, likeNumber=0, createdTime=2016-07-24, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=256459145ee, moduleTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=256459145ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904966, encodeId=64c31904966bc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=肠道菌群+计算机：定制你的健康食谱与治疗方案, objectType=article, longId=73778, objectId=00a1e3778b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00a1e3778b1, replyNumber=0, likeNumber=53, createdTime=2017-05-18, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00a1e3778b1, moduleTitle=肠道菌群+计算机：定制你的健康食谱与治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00a1e3778b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904962, encodeId=46f5190496222, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=COA 2015：张英泽：股骨颈骨折治疗方案选择策略与进展, objectType=article, longId=59202, objectId=a87b592022f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a87b592022f, replyNumber=0, likeNumber=51, createdTime=2016-02-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a87b592022f, moduleTitle=COA 2015：张英泽：股骨颈骨折治疗方案选择策略与进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a87b592022f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904957, encodeId=b149190495e7f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=日本利用人工智能抗癌 10分钟将可找到治疗方案, objectType=article, longId=54370, objectId=807e543e0b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=807e543e0b8, replyNumber=0, likeNumber=46, createdTime=2015-11-24, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=807e543e0b8, moduleTitle=日本利用人工智能抗癌 10分钟将可找到治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=807e543e0b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904965, encodeId=cd5219049650a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=耐药结核病治疗方案, objectType=article, longId=68146, objectId=dc8468146f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc8468146f7, replyNumber=0, likeNumber=90, createdTime=2016-10-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc8468146f7, moduleTitle=耐药结核病治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc8468146f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904964, encodeId=3a7a1904964ed, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=BMC Cancer：晚期鼻咽癌治疗方案比较, objectType=article, longId=61067, objectId=f3176106e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3176106e4d, replyNumber=0, likeNumber=72, createdTime=2016-07-14, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3176106e4d, moduleTitle=BMC Cancer：晚期鼻咽癌治疗方案比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3176106e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904963, encodeId=e597190496397, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Biol Chem：喜讯！黑色素瘤患者的治疗方案有了新的进展！酶抑制剂！, objectType=article, longId=60272, objectId=b363602e2ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b363602e2ec, replyNumber=0, likeNumber=70, createdTime=2016-11-02, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b363602e2ec, moduleTitle=J Biol Chem：喜讯！黑色素瘤患者的治疗方案有了新的进展！酶抑制剂！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b363602e2ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904956, encodeId=591b1904956c2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案, objectType=article, longId=52963, objectId=e4a5529632f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4a5529632f, replyNumber=0, likeNumber=85, createdTime=2016-03-18, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4a5529632f, moduleTitle=Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4a5529632f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904959, encodeId=ac521904959d8, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cancer Cell：血小板携带的肿瘤RNA可有助于诊断分类肿瘤并可提供更佳的治疗方案, objectType=article, longId=58155, objectId=71d158155e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71d158155e3, replyNumber=0, likeNumber=109, createdTime=2016-07-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71d158155e3, moduleTitle=Cancer Cell：血小板携带的肿瘤RNA可有助于诊断分类肿瘤并可提供更佳的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71d158155e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904960, encodeId=1bf01904960ac, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：多发性骨髓瘤——治疗方案怎么选？, objectType=article, longId=58987, objectId=20675898edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20675898edb, replyNumber=0, likeNumber=61, createdTime=2016-01-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20675898edb, moduleTitle=Lancet Oncol：多发性骨髓瘤——治疗方案怎么选？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20675898edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904955, encodeId=c7e31904955fb, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：新型抗结核方案治疗方案, objectType=article, longId=52930, objectId=8b345293080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b345293080, replyNumber=0, likeNumber=86, createdTime=2016-03-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b345293080, moduleTitle=Lancet：新型抗结核方案治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b345293080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904953, encodeId=8ba919049538c, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Breast Cancer Res Treat：乳腺癌患者泌尿生殖萎缩的治疗方案, objectType=article, longId=51254, objectId=d66f51254a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d66f51254a3, replyNumber=0, likeNumber=63, createdTime=2016-04-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d66f51254a3, moduleTitle=Breast Cancer Res Treat：乳腺癌患者泌尿生殖萎缩的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d66f51254a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904954, encodeId=8de91904954fd, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=歌礼申报国内自主研发全口服丙肝治疗方案临床试验, objectType=article, longId=52491, objectId=cc8252491ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc8252491ec, replyNumber=0, likeNumber=66, createdTime=2016-02-16, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc8252491ec, moduleTitle=歌礼申报国内自主研发全口服丙肝治疗方案临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc8252491ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904958, encodeId=d617190495881, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=艾滋病复方新药F/TAF在III期临床达主要终点，有望成为标准治疗方案, objectType=article, longId=55957, objectId=68175595eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68175595eff, replyNumber=0, likeNumber=51, createdTime=2016-03-23, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68175595eff, moduleTitle=艾滋病复方新药F/TAF在III期临床达主要终点，有望成为标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68175595eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904951, encodeId=8b2c1904951d8, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：对社区获得性肺炎（CAP）患者使用何种抗生素治疗方案更好（CAP-START研究）？, objectType=article, longId=48994, objectId=8ae548994f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae548994f0, replyNumber=0, likeNumber=96, createdTime=2015-12-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae548994f0, moduleTitle=NEJM：对社区获得性肺炎（CAP）患者使用何种抗生素治疗方案更好（CAP-START研究）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae548994f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904949, encodeId=825b19049493f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：霍奇金淋巴瘤传统治疗方案的优化：减少药物可获更好的疗效？, objectType=article, longId=44472, objectId=76c9444e2bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c9444e2bd, replyNumber=0, likeNumber=71, createdTime=2015-07-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c9444e2bd, moduleTitle=Lancet：霍奇金淋巴瘤传统治疗方案的优化：减少药物可获更好的疗效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c9444e2bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904952, encodeId=99fe190495242, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Watson走进14家肿瘤中心，助力医生确定更佳治疗方案, objectType=article, longId=50447, objectId=27d15044e7d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d15044e7d, replyNumber=0, likeNumber=72, createdTime=2015-06-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d15044e7d, moduleTitle=Watson走进14家肿瘤中心，助力医生确定更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d15044e7d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

原发性胆汁性肝硬化预后判断及其治疗方案

2017-04-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA Oncol：同样的治疗方案，不同部位的结肠癌，疗效却相反

2017-03-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet子刊：晚期肾脏疾病患者应怎样选择他汀类药物治疗方案？

2016-12-18

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案

2016-07-24

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

肠道菌群+计算机：定制你的健康食谱与治疗方案

2017-05-18

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

COA 2015：张英泽：股骨颈骨折治疗方案选择策略与进展

2016-02-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

日本利用人工智能抗癌 10分钟将可找到治疗方案

2015-11-24

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

耐药结核病治疗方案

2016-10-28

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

BMC Cancer：晚期鼻咽癌治疗方案比较

2016-07-14

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Biol Chem：喜讯！黑色素瘤患者的治疗方案有了新的进展！酶抑制剂！

2016-11-02

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案

2016-03-18

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cancer Cell：血小板携带的肿瘤RNA可有助于诊断分类肿瘤并可提供更佳的治疗方案

2016-07-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：多发性骨髓瘤——治疗方案怎么选？

2016-01-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：新型抗结核方案治疗方案

2016-03-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Breast Cancer Res Treat：乳腺癌患者泌尿生殖萎缩的治疗方案

2016-04-04

仁医06 (审核中...)

前往app查看评论内容

#治疗方案#

歌礼申报国内自主研发全口服丙肝治疗方案临床试验

2016-02-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

艾滋病复方新药F/TAF在III期临床达主要终点，有望成为标准治疗方案

2016-03-23

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：对社区获得性肺炎（CAP）患者使用何种抗生素治疗方案更好（CAP-START研究）？

2015-12-28

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：霍奇金淋巴瘤传统治疗方案的优化：减少药物可获更好的疗效？

2015-07-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Watson走进14家肿瘤中心，助力医生确定更佳治疗方案

2015-06-28

科室
- - 订阅+
  - 更多科室
工具
服务